Defendant in U.S. opioid kickback case claims constitutional right to smoke pot
A U.S. ex-pharmaceutical sales representative accused of paying kickbacks to induce doctors to write prescriptions for an opioid drug is asserting he has a constitutional right to continue smoking marijuana so he can remain clear-headed for his defense.
In a filing Friday, lawyers for Jeffrey Pearlman asked a federal judge for the U.S. District Court in Connecticut to modify his bail conditions so that he can continue using marijuana that was prescribed to him by a New Jersey doctor to help him kick his opioid addiction.
“Forcing him off the medical marijuana and forcing him to return to addictive opioids would impair his Sixth Amendment right to participate fully in his defense and his Fifth (Amendment) right to due process,” his attorneys Michael Rosensaft and Scott Resnik of Katten Muchin Rosenman LLP wrote.
The novel request is one of only at least three such attempts in a federal court to permit the use of medical marijuana. It is possibly the only motion of its kind to assert a Sixth Amendment defense that the failure to permit medical marijuana use could re-trigger an opioid addiction and impede a person’s ability to participate in his own defense.
“It is a very creative defense,” said Keith Stroup, the legal counsel and founder of NORML, a nonprofit that advocates for the legalization of pot. “But I can assure you there has never been a federal judge that has granted such a motion.”
A variety of state laws have legalized marijuana for medicinal use, but federal law still prohibits it. The drug is classified as a Schedule I substance, meaning it is addictive and serves no medical purpose. Many opioids, by contrast, fall under Schedule II, meaning they are addictive, but have medical uses.
Pearlman, a former Insys Therapeutics, was charged criminally in September for allegedly arranging sham speaker programs designed to encourage medical professionals to write prescriptions for a fentanyl spray.
His lawyers say Pearlman became addicted to opioids used to treat severe back and leg pain and the drugs made him “foggy” and unable to think clearly.
After being prescribed marijuana in August, they said, his pain has subsided and he is able to “think more clearly.”
Whether the judge will grant Pearlman’s request remains to be seen.
Two defendants in other federal courts previously lost their bids to continue using medical marijuana, though the facts and circumstances in those cases were different.
In this case, the U.S. Attorney’s Office has not opposed the request.
A spokesman for the office declined to elaborate further.